AUTHORIZED USE

  • Emergency uses of the vaccine have not been approved or licensed by the FDA, but have been authorized by the FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID‑19) in either individuals 6 months of age and older or as a booster dose in individuals 18 years of age and older, as appropriate.

  • The EUA for this product is in effect for the duration of the COVID‑19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.

  • For more information on the EUA authorized uses of the vaccine, refer to the Vaccine Fact Sheets for Recipients and Caregivers.

Overview for Vaccine Recipients

Primary series 1 month between shots

Initial Adult Vaccination

Looking for information on adult primary series vaccination?

Visit spikevax
(COVID‑19 vaccine, mRNA)

Booster Doses

The Moderna COVID-19 Vaccine has received emergency authorization from the FDA to provide:

  • A first booster dose to individuals 18 years of age and older who have completed a primary series with Moderna COVID‑19 Vaccine or spikevax (COVID‑19 Vaccine, mRNA) at least 5 months after the primary series;
  • A first booster dose to individuals 18 years of age and older who have completed primary vaccination with another authorized or approved COVID‑19 vaccine. The dosing interval for the heterologous booster dose is the same as that authorized for a booster dose of the vaccine used for primary vaccination;
  • A second booster dose at least 4 months after receipt of a first booster dose of any authorized or approved COVID‑19 vaccine to individuals 50 years of age and older; and
  • A second booster dose to individuals 18 years of age and older with certain kinds of immunocompromise and who have received a first booster dose of any authorized or approved COVID‑19 vaccine at least 4 months after the receipt of a first booster dose.
Learn more about booster eligibility
mRNA in a fatty particle

What Is Moderna COVID‑19 Vaccine?

The Moderna COVID‑19 Vaccine uses mRNA to provide a blueprint for your cells to build your body's defense against SARS‑CoV‑2, the virus that causes COVID‑19.

Learn more about the vaccine

What Do We Know About the Safety of the Vaccine?

Overall, approximately 39,000 participants aged
6 months and older received at least 1 dose of Moderna COVID‑19 Vaccine in 5 clinical trials.

See what is known about vaccine safety

Frequently Asked
Questions

Do you have more questions about the Moderna COVID‑19 Vaccine? Take a look at our answers to the questions we hear most often.

View FAQ